Roth Capital Predicts Increased Earnings for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZFree Report) – Investment analysts at Roth Capital raised their Q1 2025 EPS estimates for Core Scientific in a report issued on Monday, December 16th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings of ($0.13) per share for the quarter, up from their previous forecast of ($0.14). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.07) EPS, Q4 2025 earnings at $0.00 EPS, FY2025 earnings at ($0.29) EPS and FY2026 earnings at $0.34 EPS.

A number of other brokerages have also weighed in on CORZ. Cantor Fitzgerald restated an “overweight” rating and issued a $20.00 price objective on shares of Core Scientific in a report on Thursday, October 3rd. BTIG Research boosted their target price on shares of Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a research note on Monday. Macquarie upped their price objective on Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. HC Wainwright upped their price target on shares of Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $17.00 price objective on shares of Core Scientific in a report on Tuesday, September 10th. Thirteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $18.46.

View Our Latest Analysis on CORZ

Core Scientific Stock Performance

CORZ stock opened at $14.45 on Wednesday. The firm has a 50 day moving average price of $15.24 and a 200-day moving average price of $11.91. Core Scientific has a 52-week low of $2.61 and a 52-week high of $18.63. The firm has a market capitalization of $4.04 billion and a price-to-earnings ratio of -2.67.

Hedge Funds Weigh In On Core Scientific

Several hedge funds have recently bought and sold shares of the business. Rise Advisors LLC grew its stake in Core Scientific by 14.3% in the third quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock worth $95,000 after purchasing an additional 1,000 shares in the last quarter. Banque Cantonale Vaudoise bought a new position in shares of Core Scientific during the 2nd quarter worth $28,000. Sunbelt Securities Inc. purchased a new position in shares of Core Scientific during the second quarter valued at $33,000. Vontobel Holding Ltd. raised its holdings in shares of Core Scientific by 10.4% in the third quarter. Vontobel Holding Ltd. now owns 38,089 shares of the company’s stock valued at $452,000 after acquiring an additional 3,591 shares in the last quarter. Finally, Harvest Portfolios Group Inc. lifted its stake in Core Scientific by 10.1% in the third quarter. Harvest Portfolios Group Inc. now owns 55,881 shares of the company’s stock worth $663,000 after acquiring an additional 5,109 shares during the period.

Insider Buying and Selling

In other news, insider Todd M. Duchene sold 25,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total transaction of $427,500.00. Following the transaction, the insider now owns 1,661,474 shares of the company’s stock, valued at approximately $28,411,205.40. This represents a 1.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Yadin Rozov sold 105,000 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $18.11, for a total value of $1,901,550.00. Following the sale, the director now directly owns 345,239 shares of the company’s stock, valued at $6,252,278.29. This represents a 23.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 32.00% of the stock is owned by company insiders.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Articles

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.